Forte Biosciences, Inc. (FBRX) Free Cash Flow (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Free Cash Flow for 5 consecutive years, with -$3.8 million as the latest value for Q4 2020.
- On a quarterly basis, Free Cash Flow fell 412.53% to -$3.8 million in Q4 2020 year-over-year; TTM through Dec 2020 was -$18.4 million, a 528.13% decrease, with the full-year FY2024 number at -$30.7 million, down 6.75% from a year prior.
- Free Cash Flow was -$3.8 million for Q4 2020 at Forte Biosciences, up from -$7.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $16.0 million in Q2 2019 to a low of -$17.8 million in Q1 2019.
- A 5-year average of -$5.9 million and a median of -$7.5 million in 2017 define the central range for Free Cash Flow.
- Peak YoY movement for Free Cash Flow: soared 241.83% in 2019, then crashed 1997.29% in 2020.
- Forte Biosciences' Free Cash Flow stood at -$7.8 million in 2016, then fell by 15.31% to -$8.9 million in 2017, then decreased by 18.77% to -$10.6 million in 2018, then surged by 93.02% to -$742000.0 in 2019, then tumbled by 412.53% to -$3.8 million in 2020.
- Per Business Quant, the three most recent readings for FBRX's Free Cash Flow are -$3.8 million (Q4 2020), -$7.7 million (Q3 2020), and -$4.0 million (Q2 2020).